BOLT - Bolt Biotherapeutics, Inc.
4.3
-0.050 -1.163%
Share volume: 11,312
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$4.35
-0.05
-0.01%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 03-24-2025 | 05-12-2025 | 11-12-2025 | |
| Cash flow financing | 29.000 K | 0.000 | 0.000 | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | |
| Cash flow | -2.169 M | 1.186 M | 0.000 | |
| Net income | -15.936 M | -11.040 M | -7.144 M | |
| Depreciation | 426.000 K | 399.000 K | 290.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 12.232 M | 14.551 M | 17.884 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | -963.000 K | 0.000 | |
| Cash Change | -2.169 M | 1.186 M | 8.152 M |